Related Experiment Video
Updated: Jan 12, 2026
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
A study of three cases of acquired reactive perforating collagenosis mimicking calciphylaxis
Yu Zhao1, Xiao-Tong Xie1, Hai-Feng Ni1
1Department of Nephrology, Zhong Da Hospital, Southeast University, School of Medicine, Nanjing, Jiangsu, 210009, China.
Insights
Calciphylaxis (CUA) and Acquired Reactive Perforating Collagenosis (ARPC) are distinct conditions with similar skin lesions. Accurate diagnosis is crucial for appropriate treatment and improved patient outcomes in end-stage kidney disease.
Area of Science:
- Dermatology
- Nephrology
- Vascular Medicine
Background:
- Calciphylaxis (CUA) is a rare, fatal vasculopathy in end-stage kidney disease (ESKD) patients, marked by medial calcification and thrombosis.
- Acquired Reactive Perforating Collagenosis (ARPC) is a perforating dermatosis linked to systemic diseases, involving collagen elimination through the epidermis.
- Both CUA and ARPC present with clinically similar skin lesions, complicating diagnosis.
Purpose of the Study:
- To differentiate between Calciphylaxis (CUA) and Acquired Reactive Perforating Collagenosis (ARPC).
- To provide clinicians with insights for accurate diagnosis and management of these conditions.
Main Methods:
- Case report detailing three instances of ARPC misdiagnosed as CUA.
- Comparative analysis of histopathological and clinical features.
Main Results:
- Initial misdiagnosis of ARPC as CUA occurred in three presented cases.
- Highlighting the critical need for precise differentiation due to disparate treatment strategies.
Conclusions:
- Accurate diagnosis of CUA and ARPC is essential for effective treatment.
- Distinguishing between these conditions prevents treatment delays and improves patient prognosis.
Background:
Calciphylaxis, also termed calcific uremic arteriolopathy (CUA), is a rare and potentially fatal vasculopathic disorder predominantly affecting patients with end-stage kidney disease (ESKD), particularly those undergoing dialysis or who have recently received kidney transplantation. The hallmark histopathological features of CUA encompass medial calcification of systemic arterioles, intimal fibrosis, and thrombosis. In contrast, Acquired Reactive Perforating Collagenosis (ARPC), a rare perforating dermatosis frequently associated with systemic diseases, is characterized by the transcutaneous elimination of degenerated dermal collagen fibers through the epidermis. Despite the clinical resemblance of cutaneous lesions between CUA and ARPC, their therapeutic approaches differ substantially. Misdiagnosis may result in delayed appropriate treatment and consequently poor prognosis.
Case Presentation:
This report describes three cases of ARPC that were initially misdiagnosed as CUA at external institutions.
Conclusions:
This report aims to provide clinicians with valuable insights to enhance the accurate diagnosis and optimal management of these two distinct conditions.
Clinical Trial Number:
Not applicable.
Related Concept Videos
01:05Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
01:28Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...